ISO 25720 is officially titled:
"Health informatics — Genomic sequence variation — Data exchange format"
The standard provides a uniform framework for:
The key objective of ISO 25720 is to ensure that each sample can be reliably identified and traced throughout its lifecycle, even as it moves across systems or jurisdictions. It plays a critical role in areas such as:
Without standardized identification, biological samples are at risk of:
ISO 25720 helps prevent these risks by establishing a globally accepted identification and data format system, supporting both physical and electronic sample tracking.
Adopting ISO 25720 ensures consistent and reliable sample identification with wide-ranging benefits:
Enables unambiguous labeling and tracking of DNA, tissue, blood, and other specimens.
Ensures sample data is usable and consistent across LIMS, EHRs, and databases.
Reduces transcription and labeling errors that can lead to diagnostic mistakes.
Ensures test results and research findings are linked to the correct individual.
Enables secure and consistent exchange of bio sample data in research and clinical trials.
With GMC’s ISO 25720 consulting services, your organization can unlock the following operational and strategic advantages:
Meet requirements from WHO, FDA, EMA, and ISO 20387 (biobanking) frameworks.
Minimize manual errors in labeling, documentation, and logistics.
Ensure traceability of biospecimens used in genomic and clinical studies.
Promote safe, secure, and accountable bio sample management.
Standardized formats make it easier to participate in global health and research networks.
Aligns well with HL7, ISO/TS 20428, ISO 15189, and ISO 20387.
© Growth Management Corporation. All rights reserved.
Growth Management Corporation is a management consulting firm that provides consulting, training, implementation, and certification services and solutions to organizations of all sizes, and all domains.
